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Abstract
Members of longevous families live longer than individuals from similar birth cohorts and delay/escape age-related diseases. Insight into this 
familial component of longevity can provide important knowledge about mechanisms protecting against age-related diseases. This familial 
component of longevity was studied in the Leiden Longevity Study which consists of 944 longevous siblings (participants), their parents 
(N  = 842), siblings (N  = 2,302), and spouses (N  = 809). Family longevity scores were estimated to explore whether human longevity is 
transmitted preferentially through the maternal or paternal line. Standardized mortality ratios (SMRs) were estimated to investigate whether 
longevous siblings have a survival advantage compared with longevous singletons and we investigated whether parents of longevous siblings 
harbor a life-long sustained survival advantage compared with the general Dutch population by estimating lifetime SMRs (L-SMRs). We 
found that sibships with long-lived mothers and non-long-lived fathers had 0.41 (p = .024) less observed deaths than sibships with long-lived 
fathers and non-long-lived mothers and 0.48 (p = .008) less observed deaths than sibships with both parents non-long lived. Participants had 
18.6 per cent less deaths compared with matched singletons and parents had a life-long sustained survival advantage (L-SMR = 0.510 and 
0.688). In conclusion, genetic longevity studies may incorporate the maternal transmission pattern and genes influencing the entire life-course 
of individuals.
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The average human life expectancy steadily increased over the last 
200  years in industrialized countries, with record life expectancy 
increasing from 43/45 years in 1840 to 79/85 years in 2015 for males 
and females, respectively (1). Until 1950, the average increase in life 
expectancy could mainly be attributed to improved living conditions 
and better healthcare, causing a decrease in childhood and early life 
mortality (2). After 1950, the average life expectancy increased due to a 
delay of mid- and late-life mortality (3–6). Despite the average increase 
in life expectancy in the industrialized countries, significant individual 
differences in lifespan, defined as age at death, exist (7,8). In fact, a small 
group of individuals is able to survive into exceptionally old ages. This 
longevity capacity clusters within families (9–11) and on top of that, 
members of such long-lived families seem to delay or even escape age-
related disease (12–15). Hence, research into long-lived families plays a 
key role in gaining knowledge about how to prevent age-related disease.
Previous research has focused on the survival of first-degree 
relatives and spouses of long-lived persons. Siblings of centenarians 
and siblings of nonagenarian descendants had a life-long sustained 
survival advantage compared with sex- and birth cohort–matched 
controls (9,10,16). In addition, siblings, parents, and offspring of 
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nonagenarian siblings lived significantly longer than members of 
comparable birth cohorts (11). Multigenerational studies into the 
sex-specific inheritance pattern of lifespan and longevity showed 
inconsistent results however, with either paternal or maternal trans-
mission patterns (Refs. 17–33, as reviewed in Ref. 34). Despite the 
generally observed survival advantage of first-degree relatives of lon-
gevous subjects, observations on the survival of their spouses and on 
longevity inheritance patterns remain inconclusive (11,35,36).
The limitations in current inheritance pattern studies are twofold. 
First, secular trends, such as the increase of life expectancy over time, 
are not taken into account. Second, parent-offspring analysis usually 
focuses on a single child per family, thereby omitting the potential of 
a complete sibship per family (37). Furthermore, studies have selected 
long-lived persons based on different criteria, focusing either on multiple 
siblings or singletons (9–11,16). It remains to be elucidated whether the 
stringency of long-lived case selection based on the presence or absence 
of a long-lived sibling provides a survival advantage in the selected per-
sons compared with birth cohort– and sex-matched long-lived single-
tons. Apart from this, research into the survival of first-degree relatives 
and spouses of long-lived persons often struggles to obtain an accurate 
population-based control group, sometimes leading to the generaliza-
tion of a single birth year control group to other birth years (16). It is 
also difficult to compare the survival of parents of long-lived persons 
to population-based sex- and birth cohort–matched controls because 
representative cohort lifetables preceding 1900 are often unavailable, 
except for the Netherlands and Sweden (38). Overall, research is still 
inconclusive about the following issues: sex-specific inheritance pattern 
of longevity, the survival advantage of long-lived sibships compared 
with long-lived singletons and about the question whether their parents 
already had a life-long sustained survival advantage.
To investigate these three issues, we used the data available in the 
Leiden Longevity Study (LLS). The LLS currently contains 421 com-
plete three generational families, which we denote with filial 0 until 
2 (F0–F2). First, we grouped complete F1 sibships to their parental 
longevity. We defined parental longevity as belonging to the top 1 
per cent of their birth cohort (34,39) and constructed four paren-
tal groups: Group 1: both parents were long-lived (N = 1); group 
2: mother long-lived and father not long-lived (N = 17); group 3: 
father long-lived and mother not long-lived (N = 21); group 4: both 
parents were not long-lived (N = 371). We subsequently compared 
the longevity Family Scores (LFS) of the different groups. Next, we 
investigated whether longevous siblings had a survival advantage 
over sex- and birth cohort–matched singletons using standardized 
mortality ratios (SMR). We compared the survival of spouses of lon-
gevous siblings to sex- and birth cohort–matched controls. Finally, 
we estimated lifetime SMRs (L-SMRs) to determine whether parents 
of longevous siblings had a life-long sustained survival advantage.
Methods
Leiden Longevity Study
The LLS was initiated in 2002 to study genetic determinants of 
human longevity. The LLS consists of 421 families and covers two 
generations of living subjects (F1 and F2) who were born between 
1864 and 2017. Inclusion took place from 2002 until 2006. Men 
and women could participate if they were alive and aged ≥89 and 
≥91, respectively. Both men and women were recruited to have a liv-
ing sibling meeting the same criteria. Furthermore, the parents of the 
F1 participants had to be of Dutch Caucasian origin, and the siblings 
in one family had to descend from the same parents. The sex-specific 
age inclusion criteria represented individuals equal to or beyond the 
oldest 0.5 per cent of the Dutch population in 2001. There were no 
selection criteria on health or demographic characteristics. In total, 
944 longevous F1 participants, who provided blood for research 
purposes, were included in the LLS (F1). In addition, their offspring 
and the spouses of their offspring were included (F2).
Relevant for the current study is that genealogical information was 
collected for the siblings (F1; N = 2,302), parents (F0; N = 842), and 
spouses (F1; N = 809) of the longevous F1 participants (henceforth 
referred to as siblings, parents, spouses, and participants). All genea-
logical information was verified by birth or marriage certificates and 
passports whenever possible. Additionally, verification took place via 
personal cards which were obtained from the Dutch Central Bureau 
of Genealogy in The Hague. In 2017, we updated the ages at death 
and last observation via the currently centralized municipal personal 
records database. For this study, we used two generations (F0 and F1) 
consisting of 4,807 individuals in all 421 families (Figure 1 and Table 1) 
because 86 per cent from the third generation (F2) were still alive.
Lifetables
In the Netherlands, population-based cohort lifetables are available 
from 1850 until 2017 (40,41). These lifetables contain, for each 
birth year and sex, an estimate of the hazard of dying between ages 
x and x + n (hx) based on yearly intervals (N = 1) up to 99 years of 
age. Conditional cumulative hazards (Hx) and survival probabilities 
(Sx) can be derived using these hazards. In turn, we can determine to 
which sex- and birth year–based survival percentile each person of 
our study belonged to. For example, person “A” was born in 1876, 
was a female, and died at the age of 92. According to the lifetable 
information, this person belonged to the top 3 per cent survivors of 
her birth cohort, meaning that only 3 per cent of the women born 
in 1876 reached a higher age than person A. We used the lifetables 
to calculate the birth cohort and sex-specific survival percentiles for 
each individual in the LLS. Supplementary Figure A1 shows the ages 
at death corresponding to the top 10, 5, and 1 per cent survivors of 
their birth cohorts for the period 1850–1960.
Statistical Analyses
Statistical analyses were conducted using R statistics version 3.3.0 
(42).
Standardized mortality ratios
To indicate excess mortality or excess survival of groups in the LLS 
compared with a reference population, we used SMRs. An SMR is 
Figure 1. Pedigree map of an example LLS family illustrating the LLS study 
design. Circles represent women and squares represent men. Diagonal 
lines indicate that an individual is deceased. This figure indicates that some 
participants and their spouses are still alive as of the data of submission. 
Table 1 provides an elaborate overview of the LLS data. Colors indicate as 
follows: BLUE: parental generation (F0); GREEN: participants (F1); RED: 
siblings (F1); TRANSPARENT: spouses (F1).
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estimated by dividing the observed number of deaths by the expected 
number of deaths. The expected number of deaths is given by the sum 
of all individual cumulative hazards based on the birth cohort and sex-
specific lifetables of the Dutch population. An SMR between 1 and 0 
indicates excess survival, an SMR of 1 indicates that the study popula-
tion shows a similar survival to the reference population, and an SMR 
above 1 indicates excess mortality. The SMR can be estimated condi-
tional on the specific age at which an individual starts to be observed in 
the study. This was necessary to avoid selection bias if individuals in a 
study population were not at risk of dying before a specific age of entry,
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where di  = dead status (1 = dead, 0 = alive), Ht i0  = sex- and birth 
year–specific cumulative hazard based on lifetable, ti   =  timing, 
referring to age at death or last observation, t i0  = lifetable age con-
ditioning, in this case from birth, ( t i0  = 0), N = group sample size.
SMRs were estimated for all first-degree relatives (F0 and F1) of 
the LLS participants (F1) to investigate their survival compared with 
the Dutch population. Direct or indirect selection effects were taken 
into account when estimating the SMR by conditioning the lifetable 
hazards to the age at first death of a specific group. SMRs were also 
estimated for participants by conditioning to age of inclusion, which 
varies between 89 and 102 years (see Supplementary Table A1 for 
an overview of conditioning criteria). Note that the lifetables do not 
contain yearly interval information beyond the age of 99. For this 
reason, the SMR estimations were truncated at 99 years.
To estimate the SMR at every possible starting age, we restricted 
age at death or last observation at yearly thresholds between 0 and 
99  years for every group in the LLS, except for the participants 
because they were selected to have survived ≥89/91  years (men/
women). We will refer to these age-conditioned SMRs as L-SMRs. 
These L-SMRs provided insight into the specific moment the first-
degree relatives and spouses had a survival advantage during their 
lifespan. SMR and L-SMR confidence intervals were estimated using 
95% family-based bootstrap confidence intervals with 500 resam-
pling cycles to correct for familial dependencies in the LLS data.
Longevity family score
To summarize the survival of a specific study population or subsample 
on the level of families, we constructed a LFS. The LFS is related to 
the SMR, but it is estimated by subtracting the sex-, birth cohort–, 
and age-conditioned-specific cumulative hazards by event status (1 
if death and 0 if alive) for each individual in the study population. 
In a next step, the family mean is calculated which adjusts for family 
size and results in the LFS. The LFS is related to the Family Mortality 
History Score described by Rozing and colleagues (43) and the 
est(SE) described by Sebastiani and colleagues (44). The LFS ranges 
between −1 and infinity. A score of 0 indicates that the familial lon-
gevity resembles that of the normal Dutch population. A score above 
0 indicates excess survival and below 0 indicates excess mortality. 
For example, family “A” scores an LFS of 1. This indicates that we 
observe 1 death less than expected based on the Dutch population,
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where dij   =  dead status (1  =  dead, 0  =  alive) of individual j, 
Ht ij0   =  sex- and birth year–specific cumulative hazard based on 
lifetable, tij  = timing, referring to age at death or last observation, 
t ij0  =  lifetable age conditioning, in this case from birth ( t ij0  = 0), 
Ni = sibship size.
To identify the presence of a sex-specific inheritance pattern, 
four groups of F1 sibships (participants + siblings) were constructed 
according to their parental longevity. We defined parental longevity 
as belonging to the top 1 per cent of their birth cohort. Group 1: 
both parents were long-lived (N  = 1); group 2: mother long-lived 
and father not long-lived (N = 17); group 3: father long-lived and 
mother not long-lived (N = 21); group 4: both parents were not long-
lived (N  = 371). Group 1 was omitted from the analyses because 
the size was too small and 12 sibships could not be grouped due to 
missing ages at death of their parents. The LFS was used to sum-
marize F1 sibship survival relative to the parental groups. F1 LFS 
differences between the groups were tested using the nonparametric 
Mann–Whitney U test and corresponding 95 per cent exact confi-
dence intervals were reported (45).
Results
To investigate sex-specific inheritance and the presence of a life-
long sustained survival advantage in the LLS, we used two genera-
tions covering longevous participants (F1; N = 944), their parents 
Table 1. Overview of the Leiden Longevity Study Sample For Participants and First-Degree Relatives
Parents F0
Participants* 
F1 Siblings† F1 Spouses F1
Number, N 842 944 2302 809
Deceased, N (%) 820 (97) 922 (98) 1904 (83) 663 (82)
Alive, N (%) 0 (0) 22 (2) 365 (16) 27 (3)
Female, N (%) 421 (50) 595 (63) 1082 (47) 324 (40)
Range birth 
cohorts, y
1850–1894 1900–1916 1875–1941 1882–1950
Mean age, y (SD) 77 (14.2) 97 (3.6) 69 (28.3) 75 (14.5)
Median age, y (MAD) 80 (13.3) 97 (4.0) 80 (12.8) 78 (11.0)
Missing age, N (%) 22 (3) 0 (0) 33 (2) 119 (15)
Notes: *Participants are enrolled as siblings meeting the age criteria of 89 (men) or 91 years (women). †Siblings are the siblings of participants who did not meet 
the age criteria yet or who had already been deceased at the time of enrolment.
Age refers to either age at death or age at last observation. Missing age means that we have no observation at all.
MAD = Median absolute deviation; SD = Standard deviation.
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(F0; N = 842), siblings (F1; N = 2,302), and spouses (F1; N = 809) 
(Figure 1). The participants were born between 1900 and 1916, and 
63 per cent were female (N = 595). The participants’ mean age at 
death or at last observation was 97 years and 22 (2%) participants 
are currently alive. The parents were born between 1850 and 1894 
and they are all passed away with a mean age at death of 77 years. 
We were unable to retrieve the age at death of 22 parents (3%). The 
siblings were born between 1875 and 1941 and 47% were female 
(N = 1,082). The siblings mean age at death was 69 years and the 
median age at death was 80 years. Three hundred sixty-five (16%) 
siblings are currently still alive while we were unable to retrieve any 
information on the age at death for 33 (2%) siblings. The mean sib-
ship size for F1 (participants+siblings) was 7.71 (SD = 3.4) with a 
minimum of 2 and a maximum of 17 siblings. The spouses were 
born between 1882 and 1950. Forty per cent of the spouses were 
female (N = 324) and their mean age at death was 75 years. Twenty-
seven (3%) spouses are currently alive and for 119 (15%) spouses no 
age at death or last observation was available (Table 1).
LLS Data Are of High Quality
We verified the observations as described by Schoenmaker and col-
leagues based on the first 100 LLS families by estimating SMRs for 
parents, spouses, and siblings of the complete enrolled LLS (Table 2). 
We estimated an SMR of 0.688 (95% CI = 0.651–0.727) for parents, 
indicating that we observed 31.2 per cent less deaths than would 
have been expected based on single individuals from a similar birth 
cohort and sex. The SMR for siblings was 0.662 (95% CI = 0.634–
0.695), indicating that we observed 33.8 per cent less deaths than 
would have been expected based on single individuals from a similar 
birth cohort and sex. Spouses had an estimated SMR of 1.022 (95% 
CI = 0.966–1.093). This indicates that we have not found differences 
between the survival of spouses and single individuals from similar 
birth cohorts and sex.
Maternal Transmission of Longevity
To determine an inheritance pattern based on information of not just 
single individuals but an entire sibship, we used a LFS to summar-
ize sibship survival. We grouped sibships (F1, participants + siblings) 
according to their parental (F0) longevity (parental longevity was 
defined as belonging to the top 1% survivors of their birth cohort) and 
compared the median group LFS of the complete sibships. Figure 2 
shows that all F1 sibship groups, on average, had an excess survival 
compared with single individuals from the same birth cohorts and sex, 
as indicated by the median scores which were all above 0. Sibships 
with a long-lived (LL) father and a non-long-lived (NL) mother had 
1.21 (median LFS) less observed deaths in reference to the Dutch 
population and a mean sibship size of 8.34 (SD = 3.4). Sibships with 
an LL mother and an NL father had 1.62 (median LFS) less observed 
deaths with a mean sibship size of 5 (SD = 1.9) and sibships with both 
parents NL had 1.1 less observed deaths with a mean sibship size of 
7.95 (SD = 3.4). As a result, sibships with long-lived mothers and non-
long-lived fathers showed larger LFSs than sibships with long-lived 
fathers and non-long-lived mothers (median difference in LFS of 0.41; 
95% CI = 0.07–0.77; p =  .024). Similarly, they showed larger LFSs 
than sibships with both parents non-long lived (median difference in 
LFS = 0.48; 95% CI = 0.15–0.79; p = .008). We did not observe differ-
ential survival between sons and daughters with a long-lived mother 
(Supplementary Figure A2). In conclusion, we observed a maternal 
transmission pattern of human longevity with no evidence of a differ-
ential survival advantage for sons and daughters.
Last Life-Phase Survival Advantage of Siblings Over 
Singletons
To test if longevous F1 participants had a survival advantage over 
birth cohort-, sex-, and inclusion age–matched singletons, we esti-
mated sex-specific SMRs for the participants (Figure 3A). An SMR 
of 0.814 (95% CI = 0.757–0.884) was estimated for the participants, 
indicating that as a group the participants had 18.6 per cent less deaths 
than expected based on single individuals from similar birth cohorts 
and sex. Female participants had a slightly larger survival advantage 
[0.804 (95% CI = 0.738–0.894)] than male participants [0.828 (95% 
CI = 0.742–0.943)] although this difference was not significant.
Life-Long Sustained Survival Advantage of Siblings 
and Parents But not For Spouses
Whether first-degree relatives and spouses of the participants had a 
survival advantage over their entire lifetime was studied by estimat-
ing L-SMRs. Figure 3B shows that siblings had a significant survival 
advantage compared with individuals from similar birth cohorts and 
sex at any point of their lifetime distribution until the threshold of 
97 years, although the SMR at 98 years was again significant. The 
mean L-SMR was 0.680 and the median L-SMR was 0.660. No sex 
differences were identified at any age threshold. We observed that 
spouses had a nonsignificant L-SMR until age 74, indicating that 
Table 2. Sex-Specific Standardized Mortality Ratios (SMRs) For First-Degree Relatives and Spouses of LLS Participants
Sample size Observed deaths Expected deaths SMR (95% CI)
Generation 0 (F0)
 Parents of participants 842 820 1,190 0.688 (0.651–0.727)
Generation 1 (F1)
 Siblings of participants 2,302 1,867 2,816 0.663 (0.634–0.695)
 Spouses of participants 809 663 648 1.022 (0.966–1.093)
Notes: Confidence intervals have been estimated using bootstrapping with 500 cycles.
The Dutch life tables do not contain yearly interval information beyond the age of 99. For this reason, the SMR calculations have been truncated at 99 years in 
order to correctly estimate group-specific SMRs.
No significant differences between men and women have been observed for any category.
Observed deaths have been counted after the age of the first death in a group for “parents of participants,” “siblings of participants,” and “spouses of partici-
pants.” For the participants, observed deaths have been counted after the age of inclusion for each individual separately. This is to correct for selection effects in 
the data.
In line with the counting of the observed deaths, the Dutch lifetables have been age conditioned to match the counting of deaths in the different groups. Equal 
to the counting of observed deaths, the age conditioning of the lifetables was done to correct for selection effects.
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they were similar to sex- and birth cohort–matched individuals from 
the general population. Beyond age 74, there was a small but signifi-
cant survival disadvantage (min SMR = 1.09 and max SMR = 1.32) 
and from age 91 until 94 the effects were not statistically signifi-
cant anymore. Among spouses, no statistically significant differences 
between husbands and wives could be detected at any age threshold. 
The mean L-SMR was 1.050 and the median L-SMR over all age 
points was 1.030 (Figure  3C). Finally, we were able to study the 
life-long survival for parents of longevous participants (Figure 3D). 
Parents had a significant survival advantage compared with individ-
uals from the same birth cohort and sex at any point of the parents’ 
lifetime distribution until 93 years. After 93 years, the SMR estimates 
were still below 1 although not statistically significant, probably due 
to small sample size. The parental mean and median L-SMR were 
0.510 and 0.688, respectively. No sex differences were identified at 
any age threshold. Exact values corresponding to Figure 3 can be 
found in Supplementary Table A2.
Discussion
We investigated the survival of the longevous F1 LLS participants 
(who are longevous siblings) selected in the Leiden Longevity Study, 
and their F1 siblings, F0 parents, and F1 spouses. Based on the life-
span data of entire sibships (F1, participants + siblings), we observed 
a maternal transmission pattern of longevity with equal probabil-
ity to sons and daughters. Compared with inclusion age–matched 
singletons from similar birth cohorts and sex, LLS participants had 
18.6 per cent less observed deaths than expected, and thus a survival 
advantage. In the LLS, the spouses of the participants had a life-long 
sustained survival pattern similar to the general population. Finally, 
we conclude that parents and siblings of the LLS participants had 
a life-long sustained survival advantage compared with individuals 
matched on birth cohorts and sex.
Family longevity scores (FLS) were used to explore whether 
human longevity was transmitted preferentially through the mater-
nal or paternal line, using the entire sibship information instead of 
only that of one single child per family. All sibships had an increased 
survival compared with individuals from the same birth cohort and 
sex, regardless of their parental longevity, because we selected LLS 
participants to have lived ≥89 and 91 years for men and women, 
respectively. However, the median FLS for sibships with a long-lived 
mother and a non-long-lived father was 0.41 (p = .024) higher than 
for sibships with a long-lived father and a non-long-lived mother, 
and 0.48 (p = .008) higher than for sibships with both parents non-
long-lived. This indicates that in the LLS longevity was transmit-
ted preferentially via the maternal line. This maternal transmission 
of longevity is in concordance with the mitochondrial transmission 
hypothesis which posits that longevity may be transmitted through 
mitochondrial DNA from mothers to her offspring (8). Although 
this theory argues that because mitochondria are only maternally 
inherited, they are under selection pressure for optimized compati-
bility with only the female genome, we have no evidence that there 
is preferential transmission of longevity from mothers to daughters. 
Another explanation connects to Fogel’s theory of technophysio 
evolution which explains that in the turn of the 19th to the 20th 
century, childhood and early life mortality decreased significantly. 
This decrease was attributed to an increased birth weight and 
height of children and young adults, respectively (46). Since mothers 
are pivotal in this process it might be that the long-lived mothers 
were able to give birth to such healthy children whereas this may 
not have been the case for non-long-lived mothers, irrespective of 
the beneficial effect that 19th century long-lived fathers may have 
provided. The similarity in LFS for sibships with a long-lived father 
and a non-long-lived mother (LFS = 1.21) and sibships with both 
parents non-long-lived (LFS = 1.14) indicates the small influence of 
Figure 2. Median longevity family score per sibship with one or none long-
lived parent. Each gray dot represents a complete sibship. Green boxplot 
represents the group of sibships with long-lived father and a non-long-lived 
mother (N_sibships = 21; N_individuals = 177). Orange boxplot represents 
the group of sibships with a long-lived mother and a non-long-lived father 
(N_sibships  =  17; N_individuals  =  85). Light brown boxplot represents the 
group of sibships with both parents not long-lived (N_sibships  =  371; 
N_individuals = 2,949).
Figure  3. Standardized mortality ratio (SMR) for participants and lifetime 
SMR for first-degree relatives + spouses. (A) SMR for the LLS participants, 
(B) all age SMR for sibs (F1) of participants, (C) all age SMR for spouses 
(F1) of participants, and (D) all age SMR for parents (F0) of participants. The 
horizontal dotted line illustrates the SMR threshold value of 1.  The nodes 
are SMR point estimates. The error bars represent the family bootstrapped 
confidence intervals. The colors in (B), (C), and (D) illustrate the sample size 
at every cutoff. The higher the age threshold, the lower the sample size, and 
hence, the lighter the color. The bars at the right side of the subfigures show 
the sample size associated with the colors of the SMRs.
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paternal effects compared with maternal effects. This absence may 
indicate that paternal socioeconomic status in the LLS is of marginal 
influence to the intergenerational transmission of longevity (47,48). 
Sibships with a long-lived mother and a non-long-lived father had 
not only had a higher LFS, but they also had a mean sibship size of 5, 
whereas the two other categories had a mean sibship size of 8.34 and 
7.95. In general, the probability of finding long-lived subjects in fam-
ilies increases with sibship size (49). The finding of longevity among 
children in small sibships (with a long-lived mother) may therefore 
indicate that the longevity is less likely to be prominent by chance. 
The smaller sibship size of LL mothers may be explained by a trade-
off in longevity families, either based on environmental (ie limited 
economic resources) or biological (ie reproductive capacity) factors. 
The discordant parental groups were quite small (Figure 2). We iden-
tified sibships with a long-lived father but not mother, and vice versa 
(N_sibships = 21; N_individuals = 177 and N_sibships = 17; N_indi-
viduals = 85) which interestingly shows that the maternal transmis-
sion effects are found not in all, but in a subset of LLS families.
To investigate familial clustering of longevity, studies selected 
long-lived subjects based on multiple siblings or singletons (9–11,16). 
So far it was unclear whether a sibling-based selection provides a sur-
vival advantage over singletons. We showed that longevous siblings 
(F1 LLS participants) indeed had an 18.6 per cent survival advantage 
over inclusion age, birth cohort, and sex-matched longevous single-
tons. The effect can be considered large because the observational 
period focuses on the last stage of life (ages ≥89 and 91 for men and 
women), especially when taking into account that siblings of LLS 
participants, whose full-life course was observed, showed a 33.7 per 
cent survival advantage. It might even be expected that confining the 
sample to participants consisting of three or more longevous sib-
lings increases the survival advantage. We did not, however, have the 
sample size to stratify our analyses to specific numbers of longevous 
participants within a family. Furthermore, we accounted for direct 
selection effects, although we could not directly account for the pos-
sibility that more healthy persons enrolled in the LLS than unhealthy 
persons or vice versa. We, however, did not expect that this has influ-
enced our results since the first participants died only a few weeks 
after inclusion. We conclude that, when compiling a long-lived study 
cohort, selecting longevous siblings is a more stringent selection than 
longevous singletons of the same age.
Literature is inconclusive about the potential survival advan-
tage of spouses of long-lived persons (10,11,35,36). We showed, 
in a large group, that spouses of longevous LLS participants 
(N = 809) had an equal survival to the general population until the 
age of 74. Beyond 74 years, we observed a small excess mortality. 
We have no other explanation for this finding than the fact that 
this excess mortality beyond 74 years may be a function of small 
sample size. Pedersen and colleagues observed a survival advan-
tage in the long life family study for spouses of long-lived siblings 
when comparing them to a birth cohort and sex-matched control 
group. The authors point to assortative mating as a factor explain-
ing the survival advantage for spouses of longevous participants 
(10). An earlier Quebec study also reported a survival advantage 
of spouses (35) and a study of Southern Italy found male nonage-
narians to outlive their spouses, whereas this was not the case for 
female nonagenarians (36). Clearly, biological, environmental, and 
cultural factors influence survival to advanced ages in longevous 
families.
Because of unique Dutch lifetables dating back to 1850, we 
were able to show that parents of longevous LLS participants had a 
life-long sustained survival advantage compared with birth cohort 
and sex-matched controls, until at least the age of 93 years. Beyond 
94 years the confidence intervals increased due to a limited sam-
ple size. The life-long sustained survival advantage of first-degree 
relatives indicates a familial clustering of human longevity, which 
may be the result of the absence of deleterious genetic mutations 
(50,51) or the presence of genetic mutations protecting from aging-
related diseases (52). Genetic studies aimed at identifying longevity 
loci promoting a life-long survival advantage up to the highest ages 
requires a focus on extreme individuals: cases belonging to the top 
1%–5% survivors with comparable parents. Recent genetic studies 
in the large UK Biobank (50,51) focused on subjects of 70 years 
on average without a parental selection (51) or selecting on par-
ents belonging to the top 10 per cent survivors (50). This selection 
resulted in loci known to influence healthy aging and mortality in 
middle and older ages rather than exceptional longevity. As alterna-
tive to genetic influences, shared lifestyle or environmental factors 
may influence the longevity clustering in families. With the SMR 
analyses, we could not adjust for environmental and lifestyle fac-
tors. However, the fact that we found spouses to survive comparable 
to the general population and that first-degree relatives (siblings 
and parents) had a life-long sustained survival advantage suggests a 
familial/genetic influence on human longevity, possibly acting from 
early life onward.
Longevity clusters within specific families and insight into this 
familial clustering is important in gaining knowledge of factors 
involved in a life-long survival advantage up to the highest ages. 
Knowledge about the inheritance pattern of longevity may be use-
ful for genetic studies trying to discover longevity-related genes. For 
example, effects of mitochondrial genes on human longevity should 
be investigated in those families with a history of maternal transmis-
sion of human longevity. Furthermore, research aiming to establish a 
study cohort of long-lived persons should ideally take family infor-
mation into account, because we have demonstrated an enhanced 
survival for longevous siblings (LLS participants) over birth cohort– 
and sex-matched singletons. In the LLS, spouses seem comparable to 
the general population, making them a suitable comparison group 
for various health-related phenotypes as well as longevity. Lastly, 
compared with sex- and birth cohort–matched individuals, parents 
of the LLS participants at the turn of the 19th century have a life-
long sustained survival advantage up to the highest ages which was 
previously reported for the 20th century survival of siblings of lon-
gevous singletons (9,10,16). This indicates that when studying the 
determinants of longevity factors involving the entire lifespan may 
contribute and emphasize the importance of longitudinal popula-
tion–based studies in the search for protective factor for age-related 
disease.
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